Analysis Of Income And Expense [Abstract]

BioArctic - Filing #678259

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue	—	615 995 SEK	—	228 291 SEK
Material income and expense [abstract]
Other operating income (expense)	—	4 082 SEK	—	334,000 SEK
Miscellaneous other operating expense	—	8 132 SEK	—	8 337 SEK
Revenue and other operating income	—	620 077 SEK	—	228 625 SEK
Operating expense	—	367 437 SEK	—	245 961 SEK
Expenses by nature [abstract]
Classes of employee benefits expense [abstract]
Employee benefits expense	—	200 320 SEK	—	115 650 SEK
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense	—	18 428 SEK	—	14 633 SEK
Other expenses, by nature	—	50 931 SEK	—	33 015 SEK
Disclosure of attribution of expenses by nature to their function [text block]	—	—	—	—
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	—	26,000 SEK	—	- SEK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	229 220 SEK	229 220 SEK	11 179 SEK	11 179 SEK
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent	—	229 223 SEK	—	11 179 SEK